Chemoinformaics analysis of De-O-methyllasiodiplodin
Molecular Weight | 278.348 | nRot | 0 |
Heavy Atom Molecular Weight | 256.172 | nRig | 18 |
Exact Molecular Weight | 278.152 | nRing | 2 |
Solubility: LogS | -3.517 | nHRing | 1 |
Solubility: LogP | 4.625 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 44.5974 |
nHD | 2 | BPOL | 24.6746 |
QED | 0.712 |
Synth | 3.199 |
Natural Product Likeliness | 1.485 |
NR-PPAR-gamma | 0.966 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.005 |
CACO-2 | -4.809 |
MDCK | 0.0000317 |
BBB | 0.365 |
PPB | 0.976003 |
VDSS | 0.634 |
FU | 0.0215697 |
CYP1A2-inh | 0.962 |
CYP1A2-sub | 0.349 |
CYP2c19-inh | 0.842 |
CYP2c19-sub | 0.071 |
CYP2c9-inh | 0.576 |
CYP2c9-sub | 0.959 |
CYP2d6-inh | 0.928 |
CYP2d6-sub | 0.542 |
CYP3a4-inh | 0.5 |
CYP3a4-sub | 0.096 |
CL | 9.838 |
T12 | 0.728 |
hERG | 0.02 |
Ames | 0.067 |
ROA | 0.028 |
SkinSen | 0.877 |
Carcinogencity | 0.085 |
EI | 0.935 |
Respiratory | 0.539 |
NR-Aromatase | 0.473 |
Antiviral | Yes |
Prediction | 0.57534 |